Ізраїль - англійська - Ministry of Health

neopharm (israel) 1996 ltd - ceftriaxone as sodium - powder for solution for inj/inf - ceftriaxone as sodium 1000 mg/vial - ceftriaxone - ceftriaxone - * ceftriaxone-fresenius is indicated for the treatment of the following infections in adults and children including term neonates (from birth) :- bacterial meningitis- community acquired pneumonia- hospital acquired pneumonia- acute otitis media- intra-abdominal infections- complicated urinary tract infections (including pyelonephritis)- infections of bones and joints- complicated skin and soft tissue infections- gonorrhoea- syphilis- bacterial endocarditis* ceftriaxone-fresenius may be used:- for treatment of acute exacerbations of chronic obstructive pulmonary disease in adults- for treatment of disseminated lyme borreliosis (early (stage ii) and late (stage iii)) in adults and children including neonates from 15 days of age.- for pre-operative prophylaxis of surgical site infectionsin the management of neutropenic patients with fever that is suspected to be due to a bacterial infectionin the treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above* ceftriaxone-fresenius should be co-administered with other antibacterial agents whenever the possible range of causative bacteria would not fall within its spectrum.* consideration should be given to official guidelines on the appropriate use of antibacterial agents.

Мальта - англійська - Medicines Authority

pharmsol europe limited the victoria centre unit 2, lower ground floor, valletta road, mosta mst 9012 , malta - ceftriaxone - powder for solution for injection/infusion - ceftriaxone 1000 mg - antibacterials for systemic use

Ізраїль - англійська - Ministry of Health

a.l. medi-market ltd. - ceftriaxone as sodium - powder for solution for inj/inf - ceftriaxone as sodium 1 g/vial - ceftriaxone - ceftriaxone is indicated for the treatment of the following infections in adults and children including term neonates (from birth): bacterial meningitis community acquired pneumonia hospital acquired pneumonia acute otitis media intra-abdominal infections complicated urinary tract infections (including pyelonephritis) infections of bones and joints complicated skin and soft tissue infections gonorrhoea syphilis bacterial endocarditisceftriaxone may be used: for treatment of acute exacerbations of chronic obstructive pulmonary disease in adults for treatment of disseminated lyme borreliosis (early (stage ii) and late (stage iii) in adults and children including neonates from 15 days of age. for pre-operative prophylaxis of surgical site infections in the management of neutropenic patients with fever that is suspected to be due to a ceftriaxone – susceptible bacterial infection in the treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed aboveceftriaxone should be co-administered with other antibacterial agents whenever the possible range of causative bacteria would not fall within its spectrum.consideration should be given to official guidelines on the appropriate use of antibacterial agents.

Ізраїль - англійська - Ministry of Health

pharmalogic ltd - ceftriaxone as sodium - powder for solution for inj/inf - ceftriaxone as sodium 1 g/vial - ceftriaxone - ceftriaxone - ceftriaxone panpharma is indicated for the treatment of the following infections in adults and children including term neonates (from birth):- bacterial meningitis- community acquired pneumonia- hospital acquired pneumonia- acute otitis media- intra-abdominal infections- complicated urinary tract infections (including pyelonephritis)- infections of bones and joints- complicated skin and soft tissue infections- gonorrhoea- syphilis- bacterial endocarditisceftriaxone panpharma may be used:- for treatment of acute exacerbations of chronic obstructive pulmonary disease in adults- for treatment of disseminated lyme borreliosis (early (stage ii) and late (stage iii) in adults and children including neonates from 15 days of age.- for pre-operative prophylaxis of surgical site infections- in the management of neutropenic patients with fever that is suspected to be due to a ceftriaxone- susceptible bacterial infection- in the treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above ceftriaxone panpharma should be co-administered with other antibacterial agents whenever the possible range of causative bacteria would not fall within its spectrum.consideration should be given to official guidelines on the appropriate use of antibacterial agents.

Мальта - англійська - Medicines Authority

hospira uk limited horizon, honey lane, hurley, maidenhead sl6 6rj, united kingdom - ceftriaxone - powder for solution for injection - ceftriaxone 500 mg - antibacterials for systemic use

Мальта - англійська - Medicines Authority

hospira uk limited horizon, honey lane, hurley, maidenhead sl6 6rj, united kingdom - ceftriaxone - powder for solution for infusion or injection - ceftriaxone 1 g - antibacterials for systemic use

Мальта - англійська - Medicines Authority

hospira uk limited horizon, honey lane, hurley, maidenhead sl6 6rj, united kingdom - ceftriaxone - powder for solution for injection - ceftriaxone 2 g - antibacterials for systemic use

Мальта - англійська - Medicines Authority

pharmsol europe limited the victoria centre unit 2, lower ground floor, valletta road, mosta mst 9012 , malta - ceftriaxone sodium - powder for solution for infusion - ceftriaxone sodium 2 gram(s) - antibacterials for systemic use

Мальта - англійська - Medicines Authority

dali pharma gmbh brehmstrasse 56, 40239, dusseldorf,, germany - ceftriaxone sodium - powder for solution for infusion - ceftriaxone sodium 2 g - antibacterials for systemic use

Мальта - англійська - Medicines Authority

dali pharma gmbh brehmstrasse 56, 40239, dusseldorf,, germany - ceftriaxone sodium - powder for solution for injection - ceftriaxone sodium 250 mg - antibacterials for systemic use